RDoC and Mood & Anxiety Disorders: Recent Advances and Future Directions

Saturday, April 7
8:00 am - 12:00 pm

The Scientific Research Symposium (SRS) will bring together experts in the field to highlight links between mood or anxiety disorders and substance use from genetics, psychological, epidemiological, and treatment perspectives.  The goal is to provide a comprehensive overview of the state of knowledge and discuss insights from the experts toward the development of new ways of identifying, individuals at risk, determining what treatments might be effective, and develop tools to quantify the prognosis of patients with mood, anxiety and comorbid substance use disorder.

2018 Topic

The overall concept is to have an SRS with a mixture of preclinical and clinical research presenters, as well as NIMH program staff, to discuss RDoC’s accomplishments since its inception, especially its impact on thinking about mood/anxiety spectrum disorders. In addition, the speakers might forecast where RDoC will go over the next 5 years, with emphasis on its translation to clinical practice.


PINE_0.jpgDaniel Pine, MD
Chief, Development and Affective Neuroscience Unit
National Institute of Mental Health (NIMH)

NIMH Scientific Perspective

morris2014.jpgSarah Morris
Associate Director, RDoC Unit
National Institute of Mental Health (NIMH)

Senior NIMH Program Staff Perspective

Deanna-Barch_0_0.jpgDeanna Barch, PhD
Professor of Psychological & Brain Sciences
Washington University-St. Louis

Preclinical Scientific Perspective


Joel-Yager.jpgJoel Yager, MD
University of Colorado-Denver Psychiatry Department

Clinical Research and Clinical Application Perspective


Roy Perlis.jpgRoy Perlis, MD
Harvard Psychiatry Department

Clinical Research and Application



Hettema_0.jpgJohn M. (Jack) Hettema, M.D., Ph.D.
Virginia Commonwealth University




Andrew-Goddard_0.jpgAndrew W. Goddard, MD
University of California San Francisco